We chose two p53 wild-type ovarian cancer cell lines for this mouse experiment: A2780 (cisplatin-sensitive, IC50 = 1.3 μM) and RMG1 (cisplatin-resistant, IC50 = 7.5 μM). Here, TP53 is linked to ovarian carcinoma.